Acetaminophen Recruiting Phase 1 Trials for Multiple Myeloma (MM) Treatment

Indications	Status	Purpose	Phase
DBCOND0040908 (Multiple Myeloma (MM))	Recruiting	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT01998971	A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma	DB00471 (Montelukast) DB08889 (Carfilzomib) DB00480 (Lenalidomide) DB00316 (Acetaminophen) DB01075 (Diphenhydramine) DB01593 (Zinc) DB01042 (Melphalan) DB01234 (Dexamethasone) DB01041 (Thalidomide) DB00635 (Prednisone) DB08910 (Pomalidomide) DB00188 (Bortezomib) DB09331 (Daratumumab)